Skip to content
Study details
Enrolling now

Early Feasibility Study of Cartilage Defect Repair

Cytex Therapeutics, Inc.
NCT IDNCT06823089ClinicalTrials.gov data as of Apr 2026
Target enrollment

15

Study length

about 6 years

Ages

14–64

Locations

1 site in MO

About this study

Researchers are testing a new device called the ReNew Hip Implant for people with hip problems that have damaged cartilage. The trial will last about 2 years and involve up to 15 participants who are at least 14 years old and need surgery to repair their hips.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use ReNew Hip Implant
Primary goalTo establish initial safety (adverse events and device related serious adverse events) and effectiveness (pain and function) of the ReNew Hip Implant

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low12%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: To establish initial safety (adverse events and device related serious adverse events) and effectiveness (pain and function) of the ReNew Hip Implant

Secondary: Patient Reported Outcome Measures, Radiographic

Devices

implantable

Body systems

Musculoskeletal